Sign up to our newsletter

We have launched a new troponin MAb Y302 recombinant monoclonal antibody, which is expressed in a mammalian cell line and contains full-size IgG sequence derived from rabbit B cells and epitope specificity for this MAb is 83 – 100 a.a.r. of human cardiac troponin I.

A new article titled "Fragmentation of human cardiac troponin T after acute myocardial infarction" by our scientists was published in Clinica Chimica Acta journal.

We are launching a new product, recombinant thyroglobulin, Cat # 8RTG4.

Troponin I and T are the main biomarkers and gold standards for diagnostics of acute myocardial infarction (AMI). Recently high- sensitivity cTn (hs-cTn) assays, the detection limit of which is pg/ml (ng/l) rather than ng/ml, have made it possible to identify any myocardial injury, including those AMI patients, within 1 to 3 hours. This represents a potential 3-hour time saving to ensure more rapid patient management.

HF is a severe clinical and public health problem that is characterized by an increasing prevalence and economic cost. NT-proBNP, a derivative of pro-B-type natriuretic peptide (proBNP), is an established biomarker for heart failure (HF) diagnostics.

We will be attending Medlab Middle East 2023 in the beginning of February.

Seasonal flu is an acute respiratory infection caused by influenza viruses, including influenza A and influenza B. The typical symptoms include headaches, running nose, cough and muscle pain. The infection of other respiratory viruses, such as respiratory syncytial virus (RSV), can also present flu-like symptoms.

HyTest offers 5 new antibodies specific for cTnI. The antibodies are specific to epitopes 22-40 (Y306 and Y503), 83-100 (Y101), 161-178 (Y501), and 174-191 (Y502).

We are sponsoring the Cardiac Marker Dialogues meeting.

We will be attending Medica trade show 2022.

Medica 2022, the World Medicine Forum will take place 14-17 November 2022 in Düsseldorf, Germany.

The Award is given to the best published paper, as judged by an independent panel of experts, which demonstrates a remarkable scientific work in the field of cardiovascular diseases.
The Award, consisting of a certificate and a sum of 5,000 Euro,
will be presented to the first author, who is responsible for division among co-authors, at the 25th IFCC-EFLM EuroMedLab Congress to be held in Rome from 21 to 25 May 2023.

Pregnancy-associated plasma protein-A (PAPP-A) is a metalloprotease that belongs to the metzincin superfamily of zinc peptidases. Its main substrate is the insulin-like growth factor binding protein-4 (IGFBP-4). This cleavage causes the release of bound IGF, which plays an important role in promoting cell differentiation and proliferation. PAPP-A was first identified in the serum of pregnant women, hence its name. It was later shown to be expressed in multiple tissues.

We will be participating the 2022 AACC Annual Meeting & Clinical Lab Expo. The exhibition will be on July 26 - 28 in Chicago.

Human C-reactive protein (CRP) is one of the so-called acute phase proteins. CRP is produced in liver and its concentration in blood increases rapidly after a single systemic stimulus and the serum concentrations rise quickly.

We warmly congratulate Dr. Jorge Díaz-Garzón, winner of the third EFLM-HyTest Cardiac Marker award, who finally received his award at the IFCC-EFLM European Congress - EuroMedLab!

Neurofilaments are the main cytoskeletal structure proteins in neurons. They are about 10 nm in diameter, thicker than actin and thinner than myosin, and are thus classed as intermediate filaments (IFs). Neurofilaments comprise four different subunits, the stoichiometry of which varies depending on the maturity of the neuron.

HyTest sponsored SensUs in 2017 when the target molecule was NT-proBNP. In 2022 the aim is to make biosensors for measuring acute inflammation focusing on sepsis. Target molecule is interleukin-6 and we will again sponsor SensUs teams by providing IL-6 antibodies and antigens to them.

The escalation of the conflict between Russia and Ukraine last week has led to a crisis in Europe.
We are following the situation closely and give all our sympathies to the victims and the people affected by the war.

Acute myocardial infarction (AMI) causes damage of heart muscle and the release of troponin complexes in patients’ blood where it can be detected by measuring its components. Early diagnosis of AMI and other myocardial injury associated diseases related to cardiac muscle injury are important for immediate evidence-based therapy. Cardiac troponins I and T (cTnI and cTnT) are currently widely used as a recommended marker of AMI, other myocardial injury associated with postoperative myocardium trauma and many other diseases related to cardiac muscle injury diagnostics. The cTnI has been a gold standard and diagnostic cornerstone in the clinical assessment of AMI as it offers accurate and rapid diagnostics rule out.

Happy Chinese New Year!